共 111 条
[1]
Bowden CL(2005)Valproate in bipolar disorder: 2000 onwards Acta Psychiatr Scand 111 13-20
[2]
Singh V(2011)Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care World Psychiatry 10 52-77
[3]
De Hert M(2010)The role of valproate in metabolic disturbances in bipolar disorder patients J Affect Disord 124 319-323
[4]
Correll CU(2015)Valproic acid as a potentiator of metabolic syndrome in institutionalized residents on concomitant antipsychotics: fat chance, or slim to none? PT 40 126-132
[5]
Bobes J(2015)Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis World Psychiatry 14 339-347
[6]
Chang HH(2015)Management of adverse effects of mood stabilizers Curr Psychiatry Rep 17 66-76
[7]
Yang YK(2013)Adverse drug reactions induced by valproic acid Clin Biochem 46 1323-1338
[8]
Gean PW(2013)Psychotropic-induced weight gain: a review of management strategies Consultant 53 153-160
[9]
Huang HC(2012)Obesity and psychotropics CNS Neurosci Ther 18 57-63
[10]
Chen PS(2014)Role of adverse effects in medication nonadherence in bipolar disorder Harv Rev Psychiatry 22 363-366